Personalized Treatment for Hypertension?

About 50% of Americans have hypertension, yet WHICH is a preferred anti-hypertensive strategy is a random process. And pharmacogenomics may not be needed. Join host, Geoff Wall, as he evaluates a recent study evaluating the role of personalized medication selection for persons with hypertension. The GameChanger Although no genetic markers exist to determine optimal hypertensive pharmacotherapy, initial and secondary hypertensive therapy does impact outcomes. A personalized approach does produce a greater reduction in blood pressure. Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health Reference Sundström J, Lind L, Nowrouzi S, et al. Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial. JAMA. 2023;329(14):1160–1169. doi:10.1001/jama.2023.3322 Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode) CE Information Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the results of the PHYSIC study 2. Discuss the limitations of the PHYSIC study 0.05 CEU/0.5 Hr UAN: 0107-0000-23-205-H01-P Initial release date: 5/22/2023 Expiration date: 5/22/2024 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram